Animal-health firm Zoetis could launch a blockbuster, an analyst said after the pharmaceutical company posted strong results for its heartworm medicine. But Zoetis stock slid early Tuesday.
Animal-health firm Zoetis could launch a blockbuster, an analyst said after the pharmaceutical company posted strong results for its heartworm medicine. But Zoetis stock slid early Tuesday.